MDGLNasdaq GS

Madrigal Pharmaceuticals, Inc.

512.16+0.04%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelBaseline

Tier and alert level are a summary. Unlock MDGL to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

−2.33%, downReturn · 1w
−7.09%, downReturn · 1m
−2.94%, downReturn · 3m
+24.24%, upReturn · 1y
−16.72%vs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 47.

RSI (14)46.97Neutral
MACD / signal-1.77 / -1.48, caution readingBelow signal line
SMA 50524.21, caution readingPrice below
SMA 200514.38, caution readingPrice below
EMA 20519.70, caution readingPrice below
ADX (14)11.92Rangebound
+DI / −DI23.71 / 25.41−DI leading
ATR (14)18.353.6% of price — typical daily swing
Stochastic %K34.81Mid-range
Bollinger bands (20)476.36 – 551.89Inside bands
ROC (10)-4.32, caution readingNegative over 10 sessions
Trend / momentum impulseBoth falling, caution impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking MDGL reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock MDGL: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get MDGL + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock MDGL